Tandem Diabetes Care, Inc. Q4 2025 Earnings Call Summary
Tandem Diabetes Care, Inc. Q4 2025 Earnings Call Summary - Moby Surpassed $1 billion in annual sales in 2025, driven...
Tandem
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation
NEW YORK, Jan. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential...
Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same...
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential...
How Device Correction and Securities Probe Will Impact Tandem Diabetes Care (TNDM) Investors
Rosen Law Firm is investigating potential securities claims on behalf of Tandem Diabetes Care shareholders after the company previously issued...
A Look At Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Recovery
Recent share performance and business snapshot Tandem Diabetes Care (TNDM) has been under pressure recently, with the stock showing a...
